Bizarre Patents
A portable partition for use in an automobile having a seat with a seat bench and a seat backrest.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7378401 | Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases The present invention is directed to the systemic administration of Fosfluridine Tidoxil, (5-fluorouridine)-5′-phosphoric acid (3-dodecylmercapto-2-decyloxy)propylester or a salt thereof, for the treatment of intraepithelial proliferative diseases such as actinic ... | 05/27/2008 |
| 7306817 | Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof A method of treating CD33+ acute and chronic myeloid leukemia in animals including humans, using fraction nos. 1 and 9 obtained from water: methanol fraction by column chromatography, with ratio of water and methanol ranging between 1:5 to 5:1, wherein said water:me... | 12/11/2007 |
| 7258862 | Mushroom extracts having anticancer activity The invention relates to a method for treatment of chronic myelogenous leukemia (CML), Ph+ acute lymphoblastic leukemia (ALL), prostate cancer and β-globin disorders such as sickle cell anemia and β-thalassemia, comprising administration of a mycelium extract from... | 08/21/2007 |
| 7205001 | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt, complex, organic compound or ionic solution to treat tumors of epithel... | 04/17/2007 |
| 7189752 | Use of etodolac for the treatment of chronic lymphocytic leukemia A method of treating cancer is provided comprising administering an amount of etodolac or analog theteof to a subject afflicted with leukemia that is effective to reduce the viability and/or to sensitize leukemia cells to an anti-cancer agent. ... | 03/13/2007 |
| 7163703 | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt, complex, organic compound or ionic solution to treat tumors of epithel... | 01/16/2007 |
| 7132116 | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt, complex, organic compound or ionic solution to treat tumors of epithel... | 11/07/2006 |
| 7109166 | Sustained release formulation of a peptide This invention is directed to a sustained release composition comprised of Compound (A) having the formula or a pharmaceutically acceptable salt thereof, and a copolymer comprised of poly-(I)-lactic-glycolic-tart... | 09/19/2006 |
| 7105560 | Use of etodolac in the treatment of multiple myeloma A method of treating multiple myeloma (MM) is provided comprising administering an amount of etodolac to a subject afflicted with MM that is effective to selectively reduce the viability of and/or to sensitize the cancer cells to an anti-cancer agent. ... | 09/12/2006 |
| 7105561 | Use of etodolac for the treatment of prostate cancer A method of treating cancer is provided comprising administering an amount of etodolac to a subject afflicted with cancer that is effective to reduce the viability and/or to sensitize the cancer to an anti-cancer agent. ... | 09/12/2006 |
| 6967034 | Herbal-based composition for treating acute and chronic myeloid leukemia A new herbal-based composition and method for treatment of CD33+ acute and chronic myeloid leukemia by Piper betel leaf extracts, and to provide a process for the isolation of active fractions from leaves or any other plant parts of Piper betel to trea... | 11/22/2005 |
| 6964959 | Use of a methylol-containing compound to treat tumors The invention provides a method of inhibiting tumor growth in a mammal, by administering to the mammal composition containing methylol-containing compound. The composition is administered to directly contact a tumor cell at a dose sufficient to induce cell death by ... | 11/15/2005 |
| 6958359 | Vanadium compounds as anti-angiogenic agents Vanadium compounds for inhibiting angiogenesis useful for treating or preventing diabetic retinopathy, hemangiomas, cancers with abnormal blood vessel supply, restenosis following vascular injury, and the like. ... | 10/25/2005 |
| 6946484 | Formulations and methods of using nitric oxide mimetics against a malignant cell phenotype Methods and formulations for inhibiting and preventing a malignant cell phenotype by administering to cells a low dose of a nitric oxide mimetic are provided. ... | 09/20/2005 |
| 6899900 | Composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator Disclosed are a multipurpose, high-functional, alkaline solution composition, preparation therefor and use thereof as a nonspecific immunostimulator. The composition comprises 1-25 parts by weight of borax (Na2B4O7.10H2O),... | 05/31/2005 |
| 6894071 | Medical compositions for intravesical treatment of bladder cancer Anti-cancer coating compositions comprising 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-[1H-indole-4,7-dione]propenol (E09) are disclosed. More specifically, the coating compositions comprise EO9 and a formulation vehicle. The formulation vehicle improves the solubili... | 05/17/2005 |
| 6875451 | Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds The invention relates to the use of arsenic compounds to treat a variety of neoplastic diseases. The present invention encompasses the administration to a mammal of arsenic in the form of a salt, complex, organic compound or ionic solution to treat tumors of epithel... | 04/05/2005 |
| 6852344 | Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof A method of treating CD33+ acute and chronic myeloid leukemia in animals including humans, using fraction nos. 1 and 9 obtained from water:methanol fraction by column chromatography, with ratio of water and methanol ranging between 1:5 to 5:1, wherein said water:met... | 02/08/2005 |
| 6793912 | Treatment of cancers by inhalation of stable platinum-containing formulations Disclosed are methods of treating cancers by inhalation of stable platinum-containing formulations. ... | 09/21/2004 |
| 6777415 | Methods of inducing cancer cell death and tumor regression Methods are provided for treating cancer, comprising administering (1) a farnesyl protein transferase inhibitor in conjunction with (2) an additional Ras signaling pathway inhibitor to induce cancer cell death and tumor regression. ... | 08/17/2004 |
| 6774131 | Remedies for endothelin-induced diseases A pharmaceutical composition for therapeutically treating prostate cancer, the pharmaceutical composition containing N-[6-methoxy-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyri midinyl]-2-phenylethenesulfoneamide or a pharmaceutically acceptable salt thereof as the e... | 08/10/2004 |
| 6720011 | Injectable composition for cancer treatment An intravenous pharmaceutical composition comprising an aqueous solution of arsenic trioxide and sodium chloride. The composition is effective in the treatment of cancers including leukemia. Complete remission of up to 21 years have been observed for acute promyeloc... | 04/13/2004 |
| 6703395 | Cyclin dependent kinase inhibitor The present invention is based on the method of treating a patient suffering from leukemia comprising administering a therapeutically effective amount of the compound 2-([(3-hydroxypropyl)amino]-6-benzylamino)-9-isopropylpurine or a pharmaceutically ... | 03/09/2004 |
| 6645972 | Methods of treating leukemia The present invention provides a novel method for treating leukemia in a host that has been previously treated with a Bcr-Abl tyrosine kinase inhibitor comprising administering to the host a therapeutically effective amount of a compound having the formul... | 11/11/2003 |
| 6642221 | Vanadium compounds as anti-proliferative agents Vanadium compounds as anti-proliferative agents. These compounds act to disrupt mitotic and meiotic spindle formation and thus are useful to prevent cell mitosis (proliferation) and meiosis.... | 11/04/2003 |
| 6635679 | Methods and compositions for inactivating viruses The present invention relates to methods and processes of inactivating a viral contaminants in a biological source material or process intermediate by contacting the biological source material (e.g., a host cell, cell supernatant, cell lysate, blood plasm... | 10/21/2003 |
| 6632832 | Anti-cancer activity of carvedilol and its isomers The present invention provides for pharmaceutical compositions comprising carvedilol for treatment of cancer. More particularly the invention relates to the use of carvedilol for treatment of cancers of the colon, ovary, breast, prostate, pancreas, lung, ... | 10/14/2003 |
| 6620843 | Anticancer treatment using triptolide prodrugs Water soluble triptolide prodrugs are used as anticancer agents, and are found to be more effective in vivo, at lower doses, in reducing tumor size than the widely used chemotherapeutic agents 5-fluorouracil and irinotecan.... | 09/16/2003 |
| 6541509 | Method for treating neoplasia using combination chemotherapy The present invention concerns an unexpected synergistic combination of known antineoplastic agents which provides unexpectedly greater efficacy than the single agents alone. Accordingly, the present invention provides a method of treating neoplasia in a ... | 04/01/2003 |
| 6525089 | Pharmaceutical composition containing decursin A pharmaceutical composition comprising decursin and its uses as a nephrotoxicity inhibitor, an antineoplastic agent, an antidiabetic agent, and as a cancer-cell differentiation induction agent are disclosed.... | 02/25/2003 |
| 6521616 | Methods of treating tumors with taurolidine The invention provides a method of inhibiting tumor growth in a mammal, by administering to the mammal composition containing taurolidine, taurultam, or a biologically active derivative thereof. The composition is administered to directly contact a tumor ... | 02/18/2003 |
| 6518274 | Use of cyclopentabenzofuran-derivatives for combating (NF-.kappa.B)-dependent diseases The invention relates to the use of cycloventabenzofuran derivatives for the production of a medicament for the treatment of nuclear factor of .kappa.B-dependent diseases.... | 02/11/2003 |
| 6476052 | Isoindolines, method of use, and pharmaceutical compositions Substituted 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines are useful in treating inflammation, inflammatory disease, autoimmune disease, and oncogenic or cancerous conditions in a mammal. Typical embodiments are 1-oxo-2-(2,6-dioxopiperidin-3yl)4-aminoisoi... | 11/05/2002 |
| 6476002 | Treatment of chronic inflammatory diseases with CM101/GBS toxin A method of treating a chronic inflammatory disease such as rheumatoid arthritis or psoriasis includes treating a patient with a toxin derived from Group B ଲ-hemolytic Streptococcus bacteria. The purified GBS toxin, or CM101, may be administered. in... | 11/05/2002 |
| 6465512 | Leukemic cell growth inhibiting method Disclosed is a method for growth inhibition of human leukemic cells or therapeutic treatment method of a leukemic patient by using a medicament of which the effective ingredient is a methylsulfinylalkyl isothiocyanate such as 4-(methylsulfinyl)butyl isoth... | 10/15/2002 |
| 6444698 | Application of 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) as a promoter blocker of cancer This Invention relates to the use of low levels of the chemical compound 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) as a promoter blocker of specific identified cancers in men, specific identified cancers in women, prostate cancers in black men, and to... | 09/03/2002 |
| 6432924 | Method of treating disorders characterized by overexpression of cytidine deaminase or deoxycytidine deaminase A composition, device, kit and method for countering or diagnosing cytidine deaminase or deoxycytidine deaminase over-expression or a disorder associated with it, or an increase in number or toxicity of pro-inflammatory cells that over-express cytidine de... | 08/13/2002 |
| 6372726 | Methods of cancer treatment using NAALADase inhibitors The present disclosure relates to dipeptidase inhibitors, and more particularly, to novel methods of using phosphonate derivatives, hydroxyphosphinyl derivatives, and phosphoramidate derivatives to inhibit N-Acetylated -Linked Acidic Dipeptidase (N... | 04/16/2002 |
| 6312737 | Method of inducing apoptosis in cancer cells using an extract of Melothria indica Lou The invention includes a method of inducing apoptosis in cancer cells by administering an extract of Melothria indica Lou to the cancer cells. The invention also includes a method of using an extract of Melothria indica Lou to induce apoptosis in cancer c... | 11/06/2001 |
| 6258779 | Method of using fetuin to induce apoptosis in cancer cells The present invention provides the methods to isolate the proteins specifically induced apoptosis (programmed cell death) in prostate cancer cells (LNCAP), leukemia cells (HL-60), and breast cancer cells (MCF-70), but without effect in normal human lung f... | 07/10/2001 |
